Active Ingredient | Indication | Inhaler | Dose | Pharmacological Profile | Clinical Summary |
---|---|---|---|---|---|
Epinephrin (adrenaline) | Acute relief of asthma symptoms not for chronic use | pMDI | 125 µg/puff, two puffs | α and β adrenoceptor agonist rapid onset <5 min short duration <30 min | Only indicated for short-term rescue use |
Albuterol (salbutamol) | Bronchospasm of any cause | pMDI Nebulizer solution DPI | 100 µg/puff, two puffs 2.5 mg 100 µg or 200 µg/actuation | β2 adrenoceptor agonist rapid onset <5 min and short duration <4 h | Short-term rescue or prevention of exercise-induced asthma Acute bronchospasm not responding to other delivery Short-term rescue or prevention of exercise-induced asthma |
Terbutaline | Bronchospasm of any cause | DPI Nebulizer solution | 500 µg/puff; one puff 2.5 mg solution | β2 adrenoceptor agonist rapid onset <5 min and short duration <4 h | Short-term rescue or prevention of exercise-induced asthma Acute bronchospasm not responding to other delivery |
Levalbuterol | Bronchospasm of any cause | pMDI Nebulizer solution | 50 µg/puff; two puffs 31 to 125 μg | β2 adrenoceptor agonist rapid onset <5 min and short duration <4 h | Short-term rescue or prevention of exercise-induced asthma Acute bronchospasm not responding to other delivery |
Fenoterol | Bronchospasm of any cause | DPI Nebulizer solution | 12 µg/capsule 20 μg | β2 adrenoceptor agonist rapid onset <5 min and short duration <6 h | Short-term rescue or prevention of exercise-induced asthma |